Terms: = Cervical cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084 AND Prognosis
8 results:
1. A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters.
Wang W; Li X; Gao Y; Zheng H; Gao M
BMC Cancer; 2023 Aug; 23(1):720. PubMed ID: 37528420
[TBL] [Abstract] [Full Text] [Related]
2. Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods.
Bayramoglu D; Seçilmiş Kerimoğlu Ö; Bayramoğlu Z; Çintesun E; Şahin G; Karabağlı P; Çelik Ç
Ginekol Pol; 2023; 94(1):3-11. PubMed ID: 35072228
[TBL] [Abstract] [Full Text] [Related]
3. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.
Attard A; Paladino NC; Lo Monte AI; Falco N; Melfa G; Rotolo G; Rizzuto S; Gulotta E; Salamone G; Bonventre S; Scerrino G; Cocorullo G
BMC Surg; 2019 Apr; 18(Suppl 1):112. PubMed ID: 31074393
[TBL] [Abstract] [Full Text] [Related]
4. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract] [Full Text] [Related]
5. [Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to date].
Hamanishi J; Mandai M; Konishi I
Nihon Rinsho; 2017 Feb; 75(2):234-244. PubMed ID: 30562858
[TBL] [Abstract] [Full Text] [Related]
6. cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract] [Full Text] [Related]
7. Ascending colon adenocarcinoma with tonsillar metastasis: a case report and review of the literature.
Sheng LM; Zhang LZ; Xu HM; Zhu Y
World J Gastroenterol; 2008 Dec; 14(46):7138-40. PubMed ID: 19084924
[TBL] [Abstract] [Full Text] [Related]
8. [Current diagnostic method, prognosis estimation and therapy of papillary thyroid cancer: recommendations of the medical universities and the National Oncologic Institute of Budapest].
Esik O; Balázs C; Boér A; Csernay L; Földes J; Füzy M; Horváth OP; Julesz J; Kásler M; Laczi F; Leövey A; Lukács G; Németh G; Perner F; Repa I; Szabolcs I; Szentirmay Z; Trón L; Balázs G
Orv Hetil; 2000 Jan; 141(1):5-16. PubMed ID: 10673852
[TBL] [Abstract] [Full Text] [Related]
